Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNexteq Regulatory News (NXQ)

Share Price Information for Nexteq (NXQ)

Share Price is delayed by 15 minutes
Get Live Data
53.50    0.00 (0.00%)
Bid:
52.00
Ask:
55.00
Spread: 3.00 (5.769%)
Market Cap: £28.98m
NXQ Live PriceLast checked at - London Stock Exchange

Intraday Nexteq Share Chart

Director Shareholding

3 Apr 2025 07:00

RNS Number : 4275D
Nexteq PLC
03 April 2025
 

Nexteq plc

 

("Nexteq" or the "Group")

Director/PDMR Shareholding

 

 

Nexteq (AIM: NXQ), a leading technology solutions provider to customers in selected industrial markets, announces that it has been notified that Carol Thompson, Non-Executive Chair and her persons closely associated have purchased 20,000 ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") at a price of 63.84 pence per Ordinary Share. Subsequent to the purchases Carol Thompson's (and her PCAs) holding in the Company is 20,000 Ordinary Shares, representing 0.03 per cent of the Company's issued share capital.

 

Nexteq plc

Duncan Faithfull, Chief Executive Officer

Matt Staight, Chief Financial Officer

 

Tel: +44 (0)20 3597 6800

Nominated Adviser and Broker:

Cavendish Capital Markets Ltd

Matt Goode / Teddy Whiley (Corporate Finance)

Tim Redfern / Harriet Ward (ECM)

 

Tel: +44 (0) 20 7220 0500

Financial PR:

Alma Strategic Communications

Hilary Buchanan / Emma Thompson

Tel: +44 (0)20 3405 0205

 

About Nexteq

Nexteq (AIM: NXQ) is a strategic technology solutions provider to customers in selected industrial markets. Its innovative technology enables the manufacturers of global electronic equipment to outsource the design, development and supply of non-core aspects of their product offering. By outsourcing elements of their technology stack to Nexteq, customers can focus their product development effort on the most critical drivers of their business' success.

 

Our solutions are delivered through a global sales team and leverage the Group's electronic hardware, software, display and mechanical engineering expertise. Our Taiwan operation is at the heart of Asian supply networks and facilitates cost effective manufacturing and strategic supply chain management.

 

The Group operates in six countries and services over 500 customers across 47 countries.

 

Nexteq operates two distinct brands: Quixant, a specialised computer platforms provider, and Densitron, leaders in human machine interface technology, each with dedicated sales, account management and product innovation teams. Founded in 2005, and later floating on the London Stock Exchange's AIM stock market as Quixant plc, the Group rebranded to Nexteq in 2023.

 

Further information on Nexteq and its divisions can be found at www.nexteqplc.com.

 

The notifications below are made in accordance with Article 19(3) of the Market Abuse Regulation:

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Carol Thompson (and persons closely associated)

2

Reason for the notification

 

a)

Position/status

Non-Executive Chair

b)

Initial notification /Amendment

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

Nexteq plc

b)

LEI

2138003VERSWQP561X71

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 0.1 pence each

Identification code

GB00B99PCP71

 

 

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

Sale of Ordinary Shares:

Price(s)

Volume(s)

63.75 pence

62.00 pence

64.2 pence

10,0000

5,782

4,218

d)

Aggregated information

 

Purchase of Ordinary Shares:

- Aggregated volume

20,000 Ordinary Shares

 

- Price

As above

e)

Date of the transactions

2 April 2025

f)

Place of the transaction

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUUVNRVVUSRAR
Date   Source Headline
13th Oct 20254:31 pmRNSNotification of major holdings
18th Sep 202511:45 amRNSResult of General Meeting
17th Sep 20257:00 amRNSFirst Mass Production Purchase Order for Brazil
10th Sep 20259:15 amRNSNotification of major holdings
10th Sep 20259:15 amRNSNotification of major holdings
10th Sep 20257:00 amRNSInterim Results
2nd Sep 20257:00 amRNSShare Buyback, Rule 9 Waiver, Notice of GM
20th Aug 20257:00 amRNSNotice of Investor Presentation
22nd Jul 20257:00 amRNSTrading Update and Notice of Results
4th Jun 20257:00 amRNS-RProDeck wins Best of Show award at NAB Show 2025
7th May 202512:43 pmRNSGrant of Options
29th Apr 20252:55 pmRNSResult of AGM
29th Apr 20257:00 amRNSAGM Statement
3rd Apr 202510:41 amRNSReport and Accounts and Notice of AGM
3rd Apr 20257:00 amRNSDirector Shareholding
2nd Apr 20257:00 amRNSChair Appointment
31st Mar 202510:17 amRNSChange of Registered Office
19th Mar 20257:00 amRNSFinal Results
14th Mar 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
13th Mar 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Mar 20258:37 amRNSTransaction in Own Shares and Total Voting Rights
12th Mar 20257:00 amRNSNotice of Investor Presentation
11th Mar 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Mar 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Mar 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Feb 20257:00 amRNSCapital Markets Event
25th Feb 20257:00 amRNSTransaction in Own Shares and Total Voting
21st Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Feb 202510:45 amRNSTransaction in Own Shares and Total Voting Rights
7th Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
5th Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
3rd Feb 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Jan 202511:51 amRNSNotification of major holdings
22nd Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Jan 20257:00 amRNSTrading Update and Notice of Results
14th Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
13th Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
9th Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Jan 20257:00 amRNSHolding(s) in Company
7th Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights
3rd Jan 20257:00 amRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.